Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,553–3,560 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Relmada Therapeutics Inc. Sepranolone Tourette syndrome (TS) Phase 2b Ongoing Subcutaneous Neurology
Relmada Therapeutics Inc. Sepranolone Tourette syndrome (TS) Phase 2b Ongoing Subcutaneous Neurology
Relmada Therapeutics Inc. NDV-01 Bladder Cancer Phase 2 Data Released Inhalation Oncology
RenovoRx Inc. RenovoGem - (TIGeR-PaC) Locally advanced pancreatic cancer (LAPC) Phase 3 Data Released Intra-arterial Oncology
RenovoRx Inc. RenovoGem - (CouGar) Unresectable locally advanced extrahepatic cholangiocarcinoma (eCCA) Phase 3 Enrollment Initiation Intra-arterial Oncology
RenovoRx Inc. RenovoGem Cholangiocarcinoma (bile duct cancer) or eCCA Phase 2/3 Ongoing Intra-arterial Oncology
Repare Therapeutics Inc. Lunresertib (RP-6306) + Debio 0123 - (MYTHIC) Solid Tumors Phase 3 Trial Planned Oral Oncology
Repare Therapeutics Inc. RP-3500 - (TRESR) Solid tumors Phase 2 Enrollment Initiation Oral Oncology